Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 28 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

7 trials in Phase 3/4

Results Transparency

0 of 8 completed trials have results

Key Signals

9 recruiting

Enrollment Performance

Analytics

Phase 2

11(39.3%)

Phase 1

6(21.4%)

Phase 3

6(21.4%)

N/A

4(14.3%)

Phase 4

1(3.6%)

28Total

Phase 2(11)

Phase 1(6)

Phase 3(6)

N/A(4)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (28)

Showing 20 of 28 trials

NCT03919240Phase 1Recruiting

CAR-T Cell Therapy Targeting to CD19 for R/R ALL

Role: collaborator

NCT06220162Phase 2Recruiting

VAC Regimen for AML Patients Who Failed to Response to VA Regimen

Role: collaborator

NCT05376111Phase 2Recruiting

Study of Venetoclax Combined With Azacitidine Regimen in Newly Diagnosed T-ALL Patients

Role: collaborator

NCT05149365Phase 3Completed

Sitagliptin for Prevention of aGVHD After Alternative Donor Transplation

Role: collaborator

NCT05657639Phase 2Recruiting

CAV Regimen for R/R AML

Role: collaborator

NCT05657652Not ApplicableRecruiting

CAV Regimen for R/R Ph- B-ALL

Role: collaborator

NCT05901974Phase 2Recruiting

Venetoclax Combined With Azactidine in the Treatment of ALAL

Role: collaborator

NCT05566054Phase 2Recruiting

Venetoclax and Azacitidine Combined With Chidamide (VAC) for the Treatment of Newly Diagnosed Acute Monocytic Leukemia

Role: collaborator

NCT05940961Phase 2Recruiting

Inotuzumab Ozogamicin in the Treatment of MRD+ After HSCT of ALL

Role: collaborator

NCT07131033Phase 1Active Not Recruiting

Esketamine Combined With Magnesium Sulfate for Postoperative Fatigue Syndrome in Patients Undergoing Laparoscopic Cholecystectomy

Role: lead

NCT05470777Phase 2Recruiting

CD22/CD19 CAR-T and Auto-HSCT Sandwich Strategy as Consolidation Therapy for B-ALL

Role: collaborator

NCT05149378Phase 2Completed

Venetoclax Based Regimen for R/R T-ALL

Role: collaborator

NCT06920576Phase 1Active Not Recruiting

Effects of Esketamine Versus Magnesium Sulfate on Emotional State and Postoperative Pain in Patients Undergoing Nasal Endoscopic Surgery

Role: lead

NCT05190549Phase 2Completed

CAV Regimen Bridging to HSCT for R/R AL

Role: collaborator

NCT06457100Phase 1Active Not Recruiting

Esmolol Versus Lidocaine on the Quality of Postoperative Recovery in Patients Undergoing Functional Endoscopic Sinus Surgery

Role: lead

NCT03600831Phase 2Completed

Postoperative Concurrent Chemoradiotherapy Versus Radiotherapy Alone for Patients With Locoregionally Advanced Esophageal Squamous Cell Carcinoma

Role: collaborator

NCT04313335Not ApplicableCompleted

Duloxetine for PHN

Role: collaborator

NCT03719534Phase 3Completed

Haplo HCT vs Haplo-cord HCT for Patients With AML

Role: collaborator

NCT04086147Phase 2Completed

CHinese Acute Tissue-Based Imaging Selection for Lysis In Stroke -Tenecteplase

Role: collaborator

NCT05023707Phase 1Unknown

Anti-FLT3 CAR T-cell Therapy in FLT3 Positive Relapsed/Refractory Acute Myeloid Leukemia

Role: collaborator